跳至主要内容
临床试验/PACTR201508001188143
PACTR201508001188143已完成未知

An open label, randomized trial of the therapeutic efficacy, safety and tolerance of co-packaged amodiaquin plus artesunate versus co-formulated artesunate plus amodiaquine versus artemether lumefatrine for the treatment of uncomplicated Plasmodium falciparum malaria in children

Swiss Pharma Nigeria Limited0 个研究点目标入组 0 人开始时间: 2015年7月3日最近更新:
适应症

试验速览

阶段
未知
状态
已完成

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
6 Month(s) 至 15 Year(s)(—)
性别
All

入选标准

  • boby weight at least 5 kg
  • History of fever
  • microscopically confirmed pure Plasmodium falciparum infection >/= 2000/uL
  • Presence or history of fever (temp. >37.4)
  • written informed consent

排除标准

  • severe malaria
  • History of alergy to study drugs
  • Presence of concomitant illness
  • Signs of severe malnutrition
  • Patient with history of hepatic, cardiac or renal disease.

研究者

相似试验

Open randomized study for the evaluation of... | 临床试验